Metsera, Inc.

Contributing Author

Recent Articles by Metsera, Inc.

Sep-29	Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3 MTSR GlobeNewswire
Sep-11	Metsera to Present Research Highlighting its Next-Generation Obesity Portfolio at the 61st EASD Annual Meeting MTSR GlobeNewswire
Aug-27	Metsera to Present at Upcoming September Investor Conferences MTSR GlobeNewswire
Jul-28	Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress MTSR GlobeNewswire
Jun-10	Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference MTSR GlobeNewswire
Jun-09	Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i MTSR GlobeNewswire
Jun-05	Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association MTSR GlobeNewswire
May-12	Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress MTSR GlobeNewswire
May-08	Metsera to Present at Bank of America 2025 Global Healthcare Conference MTSR GlobeNewswire